knowledge
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
Next article: An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
hotspot
focus
-
STAT Wunderkinds: Ruey Hu's digital tools for parsing research
2025-09-30 20:18 -
The pink breast cancer awareness ribbon needs a redesign
2025-09-30 19:54 -
Cassava reveals details — and problems — with Alzheimer's study
2025-09-30 19:36 -
WHO may add ‘noma' to its list of neglected tropical diseases
2025-09-30 19:22 -
The strategy behind pharma's lawsuits over drug pricing reform
2025-09-30 17:46 -
Cloning humans is technically possible. It's curious no one has tried
2025-09-30 17:42